U.S. Markets open in 35 hrs, 46 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,220.96 | 32.73 | 0.29% |
| NASDAQ | 2,255.88 | -3.16 | -0.14% |
| S&P 500 | 1,242.31 | 5.48 | 0.44% |
| Day Low 11:19 AM EDT | 22.31 | |
|---|---|---|
| Day High 03:48 PM EDT | 23.86 |
|
| Range | 1.55 | |
| Volume | 276,692 | |
| 30-Day Avg. Vol. | 486,000 |
|
| Difference | -43.07% | |
| Market Cap. | 864.38 M | |
| Change | 17.55 M | |
| Shares Out. | 36.57 M | |
| Percent Traded | 0.76% | |
| Revenue (LFY) | 12.6 M | |
| Earnings (TTM) | -74.27 M | |
| Next Earnings | 9/3/08 |
|
| EPS (TTM) | -2.94 |
| 52-Wk Low 12/4/07 | 6.64 | |
|---|---|---|
| 52-Wk High 12/14/07 | 31.00 |
|
| Range | 24.36 | |
| Prev. Close 9/4/08 | 23.15 | |
| Today's Open | 23.12 | |
| Change | -0.13% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 0.4384 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | — |
When immune systems attack, Rigel Pharmaceuticals wants to be there. The drug discovery and development firm focuses its proprietary research and development efforts on three main areas: inflammatory and ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.623 3/31/08 | -0.79 3/31/08 |
-0.167
Missed
|
| Last Quarter | -0.692 6/30/08 | -0.93 6/30/08 |
-0.238
Missed
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 0.00 | 12.60 M |
| Gross Profit | -342,000.00 | -57.76 M |
| Operating Income | -35.28 M | -79.53 M |
| Net Income | -34.03 M | -74.27 M |
